Evidence map›Paper›PMID 30376595›Full record

ArticleThe Journal of pathology2019

The tyrosine phosphatase Shp-2 confers resistance to colonic inflammation by driving goblet cell function and crypt regeneration.

Jessica Gagné-Sansfacon, Ariane Langlois, Marie-Josée Langlois, Geneviève Coulombe, Sarah Tremblay, Vanessa Vaillancourt-Lavigueur, Cheng-Kui Qu, Alfredo Menendez, Nathalie Rivard

Open access · hybridAbstract read
In one paragraph

Article in The Journal of pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. SHP2 regulates the development of intestinal epithelium by modifying OSTERIXFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jessica Gagné-SansfaconDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Ariane LangloisDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Marie-Josée LangloisDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Geneviève CoulombeDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Sarah TremblayDepartment of Microbiology and Infectiology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Vanessa Vaillancourt-LavigueurDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Cheng-Kui QuDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Alfredo MenendezDepartment of Microbiology and Infectiology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.
Nathalie RivardDepartment of Anatomy and Cell Biology, Cancer Research Pavilion, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada.ORCID 0000-0002-0627-493X
Université de Sherbrooke · CAEmory University · US

Funding

Canadian Institutes of Health Research (CIHR)
6 · The paper itself

Abstract

The Src homology-2 domain-containing tyrosine phosphatase 2 (SHP-2) regulates many cellular processes, including proliferation, differentiation and survival. Polymorphisms in the gene encoding SHP-2 are associated with an increased susceptibility to develop ulcerative colitis. We recently reported that intestinal epithelial cell (IEC)-specific deletion of Shp-2 in mice (Shp-2

Indexed as

Cell MovementCell ProliferationRegenerationAdaptor Proteins, Signal TransducingAnimalsCalcium-Binding ProteinsColitisColonDisease Models, AnimalEnzyme ActivationExtracellular Signal-Regulated MAP KinasesGoblet CellsMice, TransgenicPhenotypeProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins B-rafAdaptor Proteins, Signal TransducingBraf protein, mouseCalcium-Binding ProteinsDlk1 protein, mouseDLL4 protein, mouseExtracellular Signal-Regulated MAP KinasesProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins B-rafPtpn11 protein, mousecolitisepithelial regenerationERK/MAPKgoblet cellsintestinal barrierShp-2wound healing

Identifiers

PMID30376595
PMCPMC6519201
OpenAlexW2898765161

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.